Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 May;50(5):1080–1090. doi: 10.1172/JCI106579

Immunological responses to l-asparaginase

Robert G Peterson 1,2, Robert E Handschumacher 1,2, Malcolm S Mitchell 1,2
PMCID: PMC292030  PMID: 4101590

Abstract

In a series of 40 patients treated with L-asparaginase for various neoplastic diseases, 6 patients had generalized anaphylactic reactions to L-asparaginase. Each of these reactors had antibodies detectable by passive hemagglutination, but precipitins were detectable in only one of this group of six patients. That patient had received two courses of the enzyme. 1 wk after the anaphylactic reaction, complement-fixing antibodies were present in all the patients that were studied. Specific reagin antibodies (IgE) were demonstrated in one patient by the release of histamine from his leukocytes after incubation in vitro with L-asparaginase.

Binding of L-asparaginase to serum antibodies after incubation in vitro was detected by selective precipitation of the complexes with 30% ammonium sulfate or by ultracentrifugation. Total inactivation of the enzyme did not occur even at optimal proportions or at antibody excess.

Passive hemagglutinating antibodies to L-asparaginase were present in all patients who had an allergic reaction at least 1 day before the reaction occurred, when that sample was available, and were absent in all patients who did not manifest clinical allergy. Titration of antibodies by passive hemagglutination may thus provide a means of predicting impending anaphylaxis in this system, particularly when coupled with a sudden decrease in circulating levels of L-asparaginase activity.

Full text

PDF
1080

Images in this article

1086Image
on p.1086

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARBESMAN C. E., KANTOR S. Z., ROSE N. R., WITEBSKY E. Serum sickness: serologic studies following prophylactic tetanus antitoxin. J Allergy. 1960 May-Jun;31:257–272. doi: 10.1016/0021-8707(60)90054-x. [DOI] [PubMed] [Google Scholar]
  2. Clarkson B., Krakoff I., Burchenal J., Karnofsky D., Golbey R., Dowling M., Oettgen H., Lipton A. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer. 1970 Feb;25(2):279–305. doi: 10.1002/1097-0142(197002)25:2<279::aid-cncr2820250205>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  3. Cooney D. A., Capizzi R. L., Handschumacher R. E. Evaluation of L-asparagine metabolism in animals and man. Cancer Res. 1970 Apr;30(4):929–935. [PubMed] [Google Scholar]
  4. Dolowy W. C., Henson D., Cornet J., Sellin H. Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer. 1966 Dec;19(12):1813–1819. doi: 10.1002/1097-0142(196612)19:12<1813::aid-cncr2820191208>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  5. FRICK O. L., GYENES L., SEHON A. H. Demonstration of antibodies in the sera of grass-sensitive persons by the bisdiazotized-benzidine hemagglutination technique. J Allergy. 1960 May-Jun;31:216–231. doi: 10.1016/0021-8707(60)90050-2. [DOI] [PubMed] [Google Scholar]
  6. GORDON J., ROSE B., SEHON A. H. Detection of non-precipitating antibodies in sera of individuals allergic to ragweed pollen by an in vitro method. J Exp Med. 1958 Jul 1;108(1):37–51. doi: 10.1084/jem.108.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haskell C. M., Canellos G. P., Leventhal B. G., Carbone P. P., Block J. B., Serpick A. A., Selawry O. S. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med. 1969 Nov 6;281(19):1028–1034. doi: 10.1056/NEJM196911062811902. [DOI] [PubMed] [Google Scholar]
  8. Hill J. M., Loeb E., MacLellan A., Khan A., Roberts J., Shields W. F., Hill N. O. Response to highly purified L-asparaginase during therapy of acute leukemia. Cancer Res. 1969 Aug;29(8):1574–1580. [PubMed] [Google Scholar]
  9. Hill J. M., Roberts J., Loeb E., Khan A., MacLellan A., Hill R. W. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA. 1967 Nov 27;202(9):882–888. [PubMed] [Google Scholar]
  10. Jackson R. C., Handschumacher R. E. Escherichia coli L-asparaginase. Catalytic activity and subunit nature. Biochemistry. 1970 Sep 1;9(18):3585–3590. doi: 10.1021/bi00820a013. [DOI] [PubMed] [Google Scholar]
  11. Khan A., Hill J. M. Neutralizing precipitin in the serum of a patient treated with L-asparaginase. J Lab Clin Med. 1969 May;73(5):846–852. [PubMed] [Google Scholar]
  12. LICHTENSTEIN L. M., OSLER A. G. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. doi: 10.1084/jem.120.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levy D. A., Osler A. G. Studies on the mechanisms of hypersensitivity phenomena. XIV. Passive sensitization in vitro of human leukocytes to ragweed pollen antigen. J Immunol. 1966 Aug;97(2):203–212. [PubMed] [Google Scholar]
  14. Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F., Jasmin C., Rosenfeld C. Essai de traitement de la leucémie aigue lymphoblastique par la L-asparaginase. Presse Med. 1969 Mar 15;77(13):461–463. [PubMed] [Google Scholar]
  15. Miller H. K., Salser J. S., Balis M. E. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy. Cancer Res. 1969 Jan;29(1):183–187. [PubMed] [Google Scholar]
  16. Mitchell M. S., Wade M. E., DeConti R. C., Bertino J. R., Calabresi P. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med. 1969 Mar;70(3):535–547. doi: 10.7326/0003-4819-70-3-535. [DOI] [PubMed] [Google Scholar]
  17. Oettgen H. F., Old L. J., Boyse E. A., Campbell H. A., Philips F. S., Clarkson B. D., Tallal L., Leeper R. D., Schwartz M. K., Kim J. H. Inhibition of leukemias in man by L-asparaginase. Cancer Res. 1967 Dec;27(12):2619–2631. [PubMed] [Google Scholar]
  18. Oettgen H. F., Stephenson P. A., Schwartz M. K., Leeper R. D., Tallai L., Tan C. C., Clarkson B. D., Golbey R. B., Krakoff I. H., Karnofsky D. A. Toxicity of E. coli L-asparaginase in man. Cancer. 1970 Feb;25(2):253–278. doi: 10.1002/1097-0142(197002)25:2<253::aid-cncr2820250204>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  19. Ohnuma T., Holland J. F., Nagel G., Arneault G. S. Effects of L-asparaginase in acute myelocytic leukemia. JAMA. 1969 Dec 8;210(10):1919–1921. [PubMed] [Google Scholar]
  20. PORTNOY J., SHERMAN W. B. Complement fixation studies in ragweed allergy. II. Determination of antibody in human sera to ragweed antigen by means of a complement fixation inhibition test; the relationship of antibody so determined to the passive transfer for blocking antibody. J Allergy. 1954 May;25(3):229–252. doi: 10.1016/0021-8707(54)90182-3. [DOI] [PubMed] [Google Scholar]
  21. Roberts J., Prager M. D., Bachynsky N. The antitumor activity of Escherichia coli L-asparaginase. Cancer Res. 1966 Oct;26(10):2213–2217. [PubMed] [Google Scholar]
  22. SCHWARTZ R. H., VAUGHAN J. H. IMMUNOLOGIC RESPONSIVENESS OF MAN TO PENICILLIN. JAMA. 1963 Dec 28;186:1151–1157. doi: 10.1001/jama.1963.63710130002013. [DOI] [PubMed] [Google Scholar]
  23. SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
  24. STAVITSKY A. B. Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells. J Immunol. 1954 May;72(5):360–367. [PubMed] [Google Scholar]
  25. Sahiar K., Schwartz R. S. The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. J Immunol. 1965 Aug;95(2):345–354. [PubMed] [Google Scholar]
  26. Schein P. S., Rakieten N., Gordon B. M., Davis R. D., Rall D. P. The toxicity of Escherichia coli L-asparaginase. Cancer Res. 1969 Feb;29(2):426–434. [PubMed] [Google Scholar]
  27. Sehon A. H., Gyenes L., Kisil F. T. Antibodies in sera of allergic individuals. Mod Trends Immunol. 1967;2:188–234. [PubMed] [Google Scholar]
  28. Tallal L., Tan C., Oettgen H., Wollner N., McCarthy M., Helson L., Burchenal J., Karnofsky D., Murphy M. L. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer. 1970 Feb;25(2):306–320. doi: 10.1002/1097-0142(197002)25:2<306::aid-cncr2820250206>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  29. Whelan H. A., Wriston J. C., Jr Purification and properties of asparaginase from escherichia coli B. Biochemistry. 1969 Jun;8(6):2386–2393. doi: 10.1021/bi00834a020. [DOI] [PubMed] [Google Scholar]
  30. Whitecar J. P., Jr, Bodey G. P., Harris J. E., Freireich E. J. L-asparaginase. N Engl J Med. 1970 Mar 26;282(13):732–734. doi: 10.1056/NEJM197003262821307. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES